IRWDIronwood Pharmaceuticals, Inc.
$3.86+154% 1Y
$3.86
$1.4352 weeks$5.39
What is the market doing?
Mixed
1 neutral, 2 without dataRangebound. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendRangeboundderived · Oct 8, 2026
Rangebound, no clear trend. Price is −4% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How IRWD is trading
Ironwood Pharmaceuticals, Inc. is +154% over the past year while the S&P 500 is +18%: 136 points ahead of the market.
+154%
1-year return · S&P 500 +18%
- vs 200-day average
- −3.6%
vs 200-day average · below trend, but not far
- RSI (14)
- 33
RSI (14) · neutral
- Below its 52-week high
- 28%
Below its 52-week high
Details›
- Last close2026-10-08
- $3.86
- 1 monthS&P 500 +1.6%
- −5.2%
- 1 yearS&P 500 +18%
- +154%
- 5 yearsS&P 500 +86%
- −70%
- vs 50-day average$4.16
- −7.1%
- 52-week high
- $5.39
- 52-week low
- $1.43
- Annualised volatility
- 101%
| Year | Return |
|---|---|
| 2026 (year to date) | +15% |
| 2025 | −24% |
| 2024 | −61% |
| 2023 | −7.7% |
| 2022 | +6.3% |
| 2021 | +2.4% |
| 2020 | −14% |
| 2019 | +53% |
| 2018 | −31% |
| 2017 | −2.0% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 3 of 10 | +1.6% |
| Feb | 10 | 2 of 10 | −9.3% |
| Mar | 10 | 5 of 10 | +0.62% |
| Apr | 10 | 3 of 10 | −2.0% |
| May | 10 | 4 of 10 | −6.4% |
| Jun | 10 | 9 of 10 | +6.9% |
| Jul | 11 | 7 of 11 | +0.56% |
| Aug | 11 | 2 of 11 | +0.15% |
| Sep | 11 | 2 of 11 | −2.3% |
| Oct | 11 | 4 of 11 | +1.1% |
| Nov | 10 | 8 of 10 | +16% |
| Dec | 10 | 5 of 10 | +1.4% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers, Specialty & Generic
Ranks #18 of 41 by RyuScore